Log In
Print
BCIQ
Print
Print this Print this
 

LDK378

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral small molecule anaplastic lymphoma kinase (ALK) inhibitor
Molecular Target Anaplastic lymphoma kinase (ALK)
Mechanism of ActionAnaplastic lymphoma kinase (Ki-1) (ALK) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today